Information Provided By: 
Fly News Breaks for July 29, 2019
ZBH
Jul 29, 2019 | 09:10 EDT
As reported previously, Baird analyst Jeffrey Johnson upgraded Zimmer Biomet to Outperform from Neutral. The analyst upgrade comps following Q2 results as he was encouraged by its stabilizing top-line performances, its margin/cash flow implications of the improving revenue trends, and confidence in management's ability to deliver mid-single digit+ earnings and improved free cash flow over coming years. Johnson raised his price target to $154 from $132 on Zimmer Biomet shares.
News For ZBH From the Last 2 Days
There are no results for your query ZBH
